Crystal Lore | VP, Business Development
Crystal is a recognized leader and subject matter expert in the Medicare and Medicare Advantage space. With nearly two decades of experience in building and leading service and technology solutions that support clients in the healthcare sector, Crystal has developed and implemented programs for some of the largest payers and patient aggregators in the country. Recently, she served as President and General Manager for Convey Health Solutions where she built, led and sold programs to some of the industry’s largest healthcare organizations. Her initial endeavor into the space was as Senior Vice President of New Business Development for Liberty Medical Supply which gained national recognition in the diabetes sector. The company was sold in a two billion dollar transaction to Medco Health. Crystal has a BA in Accounting from Florida State University.
Gensco Executive Team
Carlos Alfaras | President bio »
Frank Aguilar | VP, National Accounts
Crystal Lore | VP, Business Development bio »
Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs bio »
David A. Andry | Senior Director National Accounts
Lewis Archibeck | Sr. Sales Executive
Lisa Capote, Esq | General Counsel
- Skin Tears Treatment Market to Observe Strong Development by 2018-2026 April 15, 2019 Articles, Featured, Industry - [To download a printable version of this article, click here] MARKET RESEARCH April 12, 2019 more...
- Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAPORT® (Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To more...
- A Case Study of Treatment of Recalcitrant Nonpressure Chronic Ulcers Using Astero Gel Topical Hydrogel with 4% Lidocaine for Autolytic Debridement and Pain Management November 13, 2017 Articles, Clinical, Featured, Research -